Meds Apotek
MEDS Apotek AB is a Swedish online pharmacy focused on serving the outpatient market through a digital storefront and home delivery model. Its assortment includes prescription medicines, over-the-counter medicines, and a broad range of licensed traded goods such as beauty, supplements, baby, fitness, food, electronics, and household products.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenueLicensed prescription drugs ordered online and delivered to customers.
Nonprescription pharmacy products sold through the online pharmacy platform.
Non-pharmacy retail items including beauty, supplements, baby, fitness, food, electronics, and home goods.
Customers
MEDS sells primarily to Swedish consumers who want pharmacy products delivered to their homes rather than purchased in a physical store. Its customer base includes patients filling prescriptions, shoppers buying OTC medicines, and households purchasing adjacent retail goods through the same checkout and delivery flow.
Patients ordering prescribed medicines online for home delivery and convenience.
Consumers buying nonprescription pharmacy products for everyday health needs.
Customers adding beauty, supplements, baby, food, electronics, and household items to pharmacy orders.
Buyers who value customer service and qualified guidance alongside digital ordering.
Strategy
MEDS is focused on capturing share as Swedish pharmacy purchasing shifts from physical stores to e-commerce. The company emphasizes profitable growth, broad assortment, and reliable home delivery, while continuing to build its position in prescription medicines and traded goods.
The business depends on capturing the shift from physical pharmacy retail to e-commerce.
Prescription orders are a core demand driver and support repeat purchasing.
A wider assortment increases basket size and helps differentiate the online offer from physical pharmacies.
Fast delivery and advice are central to customer retention in online pharmacy.
Geography
MEDS operates in Sweden and serves the Swedish outpatient market from its Stockholm-based parent company. The business is concentrated in one country, which simplifies operations but also ties performance closely to Swedish consumer demand, regulation, and pharmacy competition.
Risks
MEDS faces competitive pressure in Swedish pharmacy retail, where online and physical players compete on price, assortment, and convenience. Its business is also exposed to inventory management, IT reliability, regulatory compliance, and dependence on key personnel, while seasonal demand patterns can make quarterly results uneven.
- Competition in Swedish pharmacy e-commerceImpact: HighLikelihood: Medium
The company competes against physical pharmacies and online rivals on price, assortment, and convenience.
Exposure: Sweden
- Inventory and product assortment riskImpact: HighLikelihood: Medium
A broad assortment requires careful stock planning to avoid shortages, excess inventory, or obsolescence.
Exposure: Prescription and traded goods
- IT and platform reliability riskImpact: HighLikelihood: Medium
The business depends on digital ordering, customer service systems, and delivery coordination.
Exposure: Online pharmacy operations
- Regulatory and licensing riskImpact: HighLikelihood: Low
Sales of prescription and OTC medicines require compliance with Swedish pharmacy and agency rules.
Exposure - SeasonalityImpact: MediumLikelihood: Low
Demand varies by quarter and the fourth quarter is usually the strongest, affecting comparability.
Exposure: Quarterly revenue and earnings
Accounting
Judgemental itemsSales are recognized when goods are delivered, so shipping and fulfillment timing affects reported revenue.
Impact: Order timing and delivery cutoffs can shift revenue between quarters
The company states that Q4 is usually the strongest quarter.
Impact: Quarterly comparisons need adjustment for seasonal demand patterns
The company discloses one-off items such as listing-related and employee incentive costs.
Impact: These items can obscure underlying operating performance
A wide assortment of medicines and traded goods increases the importance of stock provisioning and obsolescence estimates.
Impact: Write-downs or provisions can affect gross profit and working capital
Similar listed companies
Publicly listed companies with a comparable business focus.
Medivir
MVIR · Health Care
Medivir AB is a Swedish pharmaceutical company focused on the development of innovative treatments for serious diseases.
Swedish Orphan Biovitrum
SOBI · Health Care
Swedish Orphan Biovitrum AB (Sobi) is a global biopharmaceutical company dedicated to transforming the lives of individuals with rare and debilitating diseases.
Medifast Inc
MED · Miscellaneous Food Preparations & Kindred Products
Medifast is a U.S.
SynAct Pharma
SYNACT · Health Care
SynAct Pharma AB is a clinical stage biotechnology company based in Lund, Sweden, specializing in the resolution of inflammation through the selective activation of the melanocortin system.
PERRIGO Co plc
PRGO · Pharmaceutical Preparations
Perrigo Co plc is a consumer self-care company focused on over-the-counter health and wellness products sold through retail and pharmacy channels.
Oncopeptides
ONCO · Health Care
Oncopeptides is a Swedish biopharmaceutical company focused on developing and commercializing therapies for difficult-to-treat hematological diseases.
Last updated: 24/09/2026